# Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution

> **NCT07105371** · PHASE1 · COMPLETED · sponsor: **The Foundation for Orthopaedics and Regenerative Medicine** · enrollment: 18 (actual)

## Conditions studied

- Motor Disorders

## Interventions

- **BIOLOGICAL:** AlloEx exosomes

## Key facts

- **NCT ID:** NCT07105371
- **Lead sponsor:** The Foundation for Orthopaedics and Regenerative Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-14
- **Primary completion:** 2025-03-14
- **Final completion:** 2025-03-14
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07105371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07105371, "Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07105371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*